Expression of <i>hsa-MIR-204, RUNX2, PPARγ,</i> and <i>BCL2</i> in Bone Marrow Derived Mesenchymal Stem Cells from Multiple Myeloma Patients and Normal Individuals. Here, BCL2 is linked to plasma cell myeloma.